Expression of the mRNA levels for MDR1, MRP1, MRP4, and MRP5 in HIV antiretroviral naive patients: follow-up at 48 weeks after the beginning of therapy

J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):e54-6. doi: 10.1097/QAI.0b013e3181fe4c89.
No abstract available

Publication types

  • Letter

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / biosynthesis*
  • Anti-HIV Agents / administration & dosage*
  • Drug Resistance, Multiple, Viral
  • Female
  • Follow-Up Studies
  • Gene Expression Profiling
  • Gene Expression*
  • HIV Infections / drug therapy*
  • Humans
  • Male
  • Multidrug Resistance-Associated Proteins / biosynthesis*
  • Prospective Studies
  • RNA, Messenger / biosynthesis
  • Treatment Outcome
  • Viral Load
  • Viremia

Substances

  • ABCB1 protein, human
  • ABCC4 protein, human
  • ABCC5 protein, human
  • ATP Binding Cassette Transporter, Subfamily B
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Anti-HIV Agents
  • Multidrug Resistance-Associated Proteins
  • RNA, Messenger
  • multidrug resistance-associated protein 1